Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gansu Huiqin Biotechnology is a Chinese life sciences company specializing in the research, development, and large-scale production of high-end pharmaceutical intermediates and fine chemicals. Based in the Lanzhou New Area, the company focuses on nucleoside and nucleotide analogs, which are critical components for antiviral and anticancer medications. Their facilities include R&D laboratories and manufacturing lines designed to support global pharmaceutical supply chains. The company provides CDMO services, helping partners transition from laboratory-scale synthesis to industrial production. They are recognized for their expertise in complex chemical synthesis and process optimization, serving as a key supplier for various global pharmaceutical manufacturers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gansu Huiqin Biotechnology.